Back to today’s briefing

Story perspectives

FDA Approves Pioneering Pig Kidney Transplants for Trials

2/4/2025

41 10

Summary

Story summary

In a groundbreaking move, the U.S. FDA has greenlit clinical trials for transplanting genetically modified pig kidneys into patients battling end-stage renal disease. United Therapeutics will kick off the trials with six participants, eventually scaling up to 50. The first transplant is anticipated in mid-2025, offering hope to those facing a dire shortage of human kidney donors.

1 of 1

Story summary

In a groundbreaking move, the U.S. FDA has greenlit clinical trials for transplanting genetically modified pig kidneys into patients battling end-stage renal disease. United Therapeutics will kick off the trials with six participants, eventually scaling up to 50. The first transplant is anticipated in mid-2025, offering hope to those facing a dire shortage of human kidney donors.